Sigma Advanced System Ltd's Q2 FY27 numbers came in mixed. Here's a quick read of what worked, what to watch, and what management said.
| Results date | November 06, 2026 |
|---|---|
| Revenue (Q2) | Rs. 417.07 Cr |
| PAT (Q2) | Rs. 48.60 Cr |
| EBITDA margin | 20.66% |
| EPS (Q2) | Rs. 2.59 |
Q2 revenue grew 11.43% QoQ to Rs.417.07 Cr with owners' PAT up 77.63% QoQ to Rs.42.46 Cr, but the 20.66% Op EBITDA margin rests entirely on an Rs.86.10 Cr inventory-build credit — ex-credit margin was ~0.01%. H1 operating cash flow was negative Rs.212.92 Cr (CFO/PAT of (2.53)×), funded by a Rs.460 Cr preferential allotment and higher borrowings, while Sri City commenced production ahead of schedule and the board approved a fund raise up to Rs.3,000 Cr.
| Driver | Expected before results | What happened | Verdict |
|---|---|---|---|
| Revenue | "Q2 should see continued conversion" of the 155 mm / LTA backlog | Rs.417.07 Cr, +11.43% QoQ | Played out |
| Op EBITDA margin | "more likely flat-to-modestly-better vs Q1's 16% than a step-change" | 20.66% — exceeded, but driven by the Rs.86 Cr inventory credit (ex-credit ≈ nil), so the expected mechanism (Sri City savings) did not show | Partially |
| PAT optics | "owners' PAT optics depend on these [other income/tax/NCI], not on operations" | other income Rs.7.40 Cr, ETR 25.56%, NCI 12.64% — all normalized as anticipated | Played out |
| Fund-raise watch item | "Nov 6 board fund-raise outcome: mode, size and use of proceeds" | board approved up to Rs.3,000 Cr; Rs.460 Cr already raised — answered | Played out |
| Working-capital risk | "thin-liquidity, working-capital-heavy project-converter position" | H1 CFO Rs.(212.92) Cr; FCF Rs.(276.20) Cr — materialized | Played out |
| FX tailwind on 80–85% international base | "rupee weaker over the quarter" | no geographic/FX disclosure in the filing | Not observable |
| Munitions India CCF MoU conversion; Sri City utilization detail | open watch items | not addressed in the filing — remains open for the call | Not observable |
Read our full results preview.
| What management said | Where | What happened | Verdict |
|---|---|---|---|
| Op EBITDA +2–4% by end FY27 from UK→India transfer | company Q1 FY27 investor presentation / AGM guidance ("EBITDA improvement of 2–4% by the end of FY27") | Q2 Op EBITDA margin 20.66% vs Q1 16.28% — but the driver is the inventory-build credit, not transfer savings (ex-credit ≈ nil); margin guide is on the company's Op EBITDA basis, matched here | On Track on direction |
| Further +4–6% through FY28 | same sources | not yet measurable | Too Early |
| Sri City commencement "on track for commencement in the third quarter" | Q1 FY27 presentation | production commenced Sep 10, 2026 (Q2, ~3 weeks in quarter) — ahead of guide | Met |
| NATO 155 mm order (USD 102.23 Mn) execution within 12 months of Oct 26, 2026 | company order-win announcement | post-quarter award; no execution disclosure | Too Early |
| US$19.70 Mn ancillary order execution by Q2 2027 | company order-win announcement | not addressed in the filing | Too Early |
| Fund raise | Nov 3 intimation ("consider raising funds… size not yet specified") | board approved up to Rs.3,000 Cr on Nov 6, 2026; Rs.460 Cr preferential done | On Track |
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.